The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary slow-flow phenomenon

Int J Cardiovasc Imaging. 2022 Jan;38(1):5-13. doi: 10.1007/s10554-021-02387-w. Epub 2021 Aug 28.

Abstract

In this study, we aimed to investigate the relationship between high triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) ratio and coronary slow flow phenomenon (CSFP) in patients undergoing elective coronary angiography for suspected coronary artery disease. This prospective study included a total of 84 CSFP patients and 83 controls with normal coronary flow, as evidenced by coronary angiography. The Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) was used to measure the coronary blood flow velocity. The lipid profiles were analyzed and TG/HDL-C ratio were calculated dividing absolute TG levels by absolute HDL-C levels in peripheral blood. The median TG/HDL-C ratio was higher in the CSFP group than the control group (3.4 [2.6 to 4.9] vs. 2.3 [1.8 to 3], respectively; p < 0.001). The multivariate logistic regression analysis revealed that TG/HDL-C ratio was an independent predictor of CSFP (odds ratio [OR] 1.78, 95% confidence interval [CI] 1.59-2.32; p = 0.001) and TG/HDL-C ratio was positively correlated with the TFC in the CSFP group (r = 0.311, p < 0.001). The area under the receiver operating characteristic curve of TG/HDL-C for the diagnosis of CSFP was 0.73 (95% CI 0.65-0.81; p < 0.001). If a cut-off value of 2.75 was used, higher levels of TG/HDL-C ratio could predict the presence of CSFP with 72% sensitivity and 71% specificity. Our study results suggest that TG/HDL-C ratio is associated with CSFP and may be a useful biomarker for predicting CSFP and its severity.

Keywords: Coronary slow-flow phenomenon; Thrombolysis in Myocardial Infarction frame count; Triglyceride/high-density lipoprotein cholesterol ratio.

MeSH terms

  • Cholesterol, HDL / blood*
  • Coronary Angiography
  • Coronary Artery Disease / diagnostic imaging*
  • Humans
  • No-Reflow Phenomenon* / diagnostic imaging
  • Predictive Value of Tests
  • Prospective Studies
  • Triglycerides / blood*

Substances

  • Cholesterol, HDL
  • Triglycerides